Blood Protein Changes May Unravel Long COVID Mysteries
Links between complement and coagulation systems could lead to long COVID therapies
Source: medpagetoday.com
📰 Wolfram Ruf News
Page 2 - Wolfram Ruf News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wolfram Ruf. Real-time updates on events, politics, business and more.
ARCA biopharma Reports Topline Results for ASPEN-COVID-19
For the entire cohort of COVID-19 hospitalized patients, the pooled lower and higher rNAPc2 dose groups demonstrated a reduction compared to baseline in...
United States Derek Cole Wolfram Ruf Michael Bristow Exchange Commission Professor Of Medicine University Colorado
Source: globenewswire.com
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial ... ARCA biopharma, Inc.December 15, 2020 GMT rNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patients, including after availability of vaccines rNAPc2 is the only novel compound being developed for COVID-19 Associated Coagulopathy Topline trial data anticipated in the second qua...
Source: apnews.com